脓毒症相关死亡率、资源利用与医疗费用:倾向匹配队列研究
该研究基于加拿大安大略省行政数据,纳入2012年4月1日至2016年3月31日住院成人(≥18岁),用Sepsis-2编码算法识别脓毒症病例,并按倾向评分、年龄、性别、入院类型和入院日期1:1匹配非脓毒症住院对照。270,669例脓毒症中196,922例(73%)匹配成功,其中严重脓毒症64,204例、非严重脓毒症132,718例。中位随访2.0年,严重脓毒症死亡率高于对照(HR 1.66;95%CI 1.63-1.68),严重和非严重脓毒症再住院率均高于对照(HR 1.53;95%CI 1.50-1.55和HR 1.41;95%CI 1.40-1.43)。1年增量费用严重脓毒症为$29,238(95%CI $28,568-$29,913),非严重脓毒症为$9,475(95%CI $9,150-$9,727)。
要点
- 严重脓毒症患者长期死亡率显著高于匹配对照:HR 1.66(95%CI 1.63-1.68),中位随访2.0年。
- 严重脓毒症再住院率高于对照:HR 1.53(95%CI 1.50-1.55);非严重脓毒症亦高:HR 1.41(95%CI 1.40-1.43)。
- 1年增量医疗费用:严重脓毒症$29,238(95%CI $28,568-$29,913),非严重脓毒症$9,475(95%CI $9,150-$9,727),均为加拿大元2018年值。
- 脓毒症幸存者出院后需有效照护,以减少死亡、再住院和费用负担。
适用人群与场景
- 加拿大安大略省2012年4月1日至2016年3月31日住院的成人(≥18岁),随访至2017年3月31日。
- 脓毒症病例用经校验的ICD-10编码算法(Sepsis-2定义)识别,包括伴器官功能障碍(严重脓毒症)和不伴器官功能障碍(非严重脓毒症)。
- 其余住院患者为潜在对照,按倾向评分、年龄、性别、入院类型和入院日期1:1匹配。
诊断标准与关键阈值
- 脓毒症识别采用经校验的ICD-10编码算法(Sepsis-2定义),包括严重脓毒症(伴器官功能障碍)和非严重脓毒症(感染不伴器官功能障碍)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:基于行政数据的倾向匹配人群队列研究;地点:加拿大安大略省;无干预。
- 270,669例脓毒症中196,922例(73%)匹配成功:严重脓毒症64,204例,非严重脓毒症132,718例。
- 中位随访2.0年,严重脓毒症死亡率高于对照:HR 1.66(95%CI 1.63-1.68)。
- 严重脓毒症再住院率高于对照:HR 1.53(95%CI 1.50-1.55);非严重脓毒症:HR 1.41(95%CI 1.40-1.43)。
- 1年增量费用(加拿大元2018):严重脓毒症$29,238(95%CI $28,568-$29,913);非严重脓毒症$9,475(95%CI $9,150-$9,727)。
证据类型、等级与局限
- 证据类型:基于行政数据的倾向匹配回顾性队列研究;原文未给出证据等级或推荐强度。
- 局限:回顾性设计、使用行政编码算法识别脓毒症(Sepsis-2定义)、单省数据,原文未提及其他局限。
对床旁实践的改变
- 脓毒症幸存者出院后长期死亡、再住院和费用风险高,应重视出院后照护;原文未给出具体干预措施。
- 严重脓毒症患者出院后风险尤其突出(死亡率HR 1.66,再住院HR 1.53),非严重脓毒症患者再住院风险亦升高(HR 1.41)。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine long-term mortality, resource utilization, and healthcare costs in sepsis patients compared to hospitalized nonsepsis controls.
DESIGN: Propensity-matched population-based cohort study using administrative data.
SETTING: Ontario, Canada.
PATIENTS: We identified a cohort of adults (≥ 18) admitted to hospitals in Ontario between April 1, 2012, and March 31, 2016, with follow-up to March 31, 2017. Sepsis patients were flagged using a validated International Classification of Diseases, 10th Revision-coded algorithm (Sepsis-2 definition), including cases with organ dysfunction (severe sepsis) and without (nonsevere). Remaining hospitalized patients were potential controls. Cases and controls were matched 1:1 on propensity score, age, sex, admission type, and admission date.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Differences in mortality, rehospitalization, hospital length of stay, and healthcare costs were estimated, adjusting for remaining confounders using Cox regression and generalized estimating equations. Of 270,669 sepsis cases, 196,922 (73%) were successfully matched: 64,204 had severe and 132,718 nonsevere sepsis (infection without organ dysfunction). Over follow-up (median 2.0 yr), severe sepsis patients had higher mortality rates than controls (hazard ratio, 1.66; 95% CI, 1.63-1.68). Both severe and nonsevere sepsis patients had higher rehospitalization rates than controls (hazard ratio, 1.53; 95% CI, 1.50-1.55 and hazard ratio, 1.41; 95% CI, 1.40-1.43, respectively). Incremental costs (Canadian dollar 2018) in sepsis cases versus controls at 1-year were: $29,238 (95% CI, $28,568-$29,913) for severe and $9,475 (95% CI, $9,150-$9,727) for nonsevere sepsis.
CONCLUSIONS: Severe sepsis was associated with substantially higher long-term risk of death, rehospitalization, and healthcare costs, highlighting the need for effective postdischarge care for sepsis survivors.
参考来源
- Farrah K, McIntyre L, Doig CJ, et al. Sepsis-Associated Mortality, Resource Use, and Healthcare Costs: A Propensity-Matched Cohort Study. Crit Care Med. 2021. PMID: 33372748. doi:10.1097/CCM.0000000000004777
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。